FDA 表示,Abeona 必须满足额外的CMC 要求才...查看全文
Abeona Therapeutics(ABEO)06-08 04:35
$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-023117 Size: 5 KB 网页链接查看全文
Abeona Therapeutics(ABEO)06-08 04:35
$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-023122 Size: 5 KB 网页链接查看全文
Abeona Therapeutics(ABEO)06-12 19:05
$Abeona Therapeutics(ABEO)$ S-3 Registration statement under Securities Act of 1933 Accession Number: 0001493152-24-023541 Act: 33 Size: 1 MB 网页链接查看全文
Abeona Therapeutics(ABEO)06-18 05:25
$Abeona Therapeutics(ABEO)$ S-3/A [Amend] Registration statement under Securities Act of 1933 Accession Number: 0001493152-24-024171 Act: 33 Size: 646 KB 网页链接查看全文
Abeona Therapeutics(ABEO)06-21 04:35
$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-024527 Size: 5 KB 网页链接查看全文
Abeona Therapeutics(ABEO)07-10 04:35
$Abeona Therapeutics(ABEO)$ 8-K Current report, items 5.03 and 9.01 Accession Number: 0001493152-24-026640 Act: 34 Size: 362 KB 网页链接查看全文
Abeona Therapeutics(ABEO)07-10 04:45
$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-026648 Size: 5 KB 网页链接查看全文
Abeona Therapeutics(ABEO)07-10 04:45
$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-026641 Size: 4 KB 网页链接查看全文
Abeona Therapeutics(ABEO)05-04 05:25
$Abeona Therapeutics(ABEO)$ 8-K Current report, items 1.01, 8.01, and 9.01 Accession Number: 0001493152-24-017768 Act: 34 Size: 1 MB 网页链接查看全文
Pharmayang2018-05-15 14:07
$Abeona Therapeutics Inc.(ABEO)$
这公司的gene therapy有三个indication比较领先,MPS IIIA, MPS IIIB (粘多糖症),和 Recessive Dystrophic Epidermolysis Bullosa (RDEB,表皮松解症)。MPS III从婴儿开始,体内蓄积heparan sulphate,对身体造成伤害,最终导致死亡。RDEB导致身上表...查看全文
Pharmayang2018-02-21 19:39
$Abeona Therapeutics Inc.(ABEO)$ biomarker 数据很好,临床统计结果还行,但不算very impressive,因为只有三到四个病人。其中一,两个病人的disease progress slow down,另一两个和其他标准疗法差不多(或稍差)。不过现在估值算比较合理了,长线考虑可以进一些pilot position。查看全文
张小丰2018-02-17 12:19
回复@wuya1019: 这个是另外一个更早期的项目//@wuya1019:回复@Stevevai1983:$Abeona Therapeutics Inc.(ABEO)$ 今天在公布Sanfilippo B的早期数据后股价大涨。对比$拜玛林制药(BMRN)$ ,ABEO的药物效果和安全性均占优势,所以BMRN跌了2%,ABEO涨了14%。怎么看 淘沙写的这个公司?查看全文
淘沙见金2018-02-08 10:42
$Abeona Therapeutics Inc.(ABEO)$ 今天在公布Sanfilippo B的早期数据后股价大涨。对比$拜玛林制药(BMRN)$ ,ABEO的药物效果和安全性均占优势,所以BMRN跌了2%,ABEO涨了14%。跟各位分享一下1月31号写的ABEO简析:网页链接查看全文
淘沙见金2018-01-31 11:32
网页链接 这篇评论文章值得一读,里面提到了James Wilson团队研究的几个不足之处:First, the number of animals included in the work was small. Second, the vector they use is research grade, not clinical grade. Finally, they use AAV...查看全文
淘沙见金2018-01-30 23:19
Gene Therapy stocks getting rocked by James Wilson's new paper raising severe tox concerns. 网页链接 The present results and those of another recent study utilizing a different AAV9 variant and transgene indicate that sys...查看全文
Guoran2017-10-15 09:11
$爱美医疗(FOLD)$ ,$Abeona Therapeutics Inc.(ABEO)$
今天八一八perceptive advisors二季度报告中的第一重仓爱美医疗,Amicus Therapeutics, Inc. (Nasdaq: FOLD)。作为今年的明星医药股之一,FOLD股价由年初不足5美元上涨到近期最高16.6美元。目前市值23亿。
Amicus Therapeutics自...查看全文
LHTSAI2017-10-11 21:54
$Abeona Therapeutics Inc.(ABEO)$
Abeona Therapeutics (NASDAQ:ABEO) initiated with Buy rating and $32 (83% upside) price target by Citigroup. 不得不說資本市場的力量, 喊一喊, 水就會凍結查看全文
智通财经APP获悉,11月27日,Abeona Therapeutics(ABEO.US)宣布,美国FDA已接受其在研疗法pz-cel(prademagene zamikeracel,EB-101)的生物制品许可申请(BLA),并授予优先审评资格,该疗法是一款自体、COL7A1基因校正表皮片,用于隐性... 网页链接
$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-026645 Size: 4 KB 网页链接
$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-026641 Size: 4 KB 网页链接
$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-026644 Size: 4 KB 网页链接
$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-026642 Size: 5 KB 网页链接
$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-026643 Size: 4 KB 网页链接
$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-026646 Size: 5 KB 网页链接
$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-026647 Size: 5 KB 网页链接
$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-026649 Size: 5 KB 网页链接
$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-026648 Size: 5 KB 网页链接
$Abeona Therapeutics(ABEO)$ 8-K Current report, items 5.03 and 9.01 Accession Number: 0001493152-24-026640 Act: 34 Size: 362 KB 网页链接